首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Biochimica et biophysica acta-molecular basis of disease

缩写:BBA-MOL BASIS DIS

ISSN:0925-4439

e-ISSN:1879-260X

IF/分区:4.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2446
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sawssen Bouali,Xunzhen Zheng,Chris Figy et al. Sawssen Bouali et al.
RKIP (Raf Kinaes Inhibitory Protein) is ubiquitously expressed in almost all normal tissues of metazoans. Consistent with its negative regulatory role in cell proliferation and survival, RKIP expression is progressively downregulated in can...
Qing Zhang,Yingzhou Hong,Chongjie He et al. Qing Zhang et al.
Bladder cancer remains a major cause of global mortality with limited therapies. Here, we reported that epigenetic regulator EP300 acts as oncogenic role in bladder cancer. Public data show EP300 mutations correlated with better prognosis, ...
Hang Wu,Xuan Jiang,Jieyun Cai et al. Hang Wu et al.
Delayed healing of diabetic wounds (DW) represents a significant complication among diabetic patients, for which current therapeutic approaches remain suboptimal. Accumulating evidence indicates that fibroblast senescence plays a critical r...
Kexin Zhang,Chengxia Kan,Hongyan Qiu et al. Kexin Zhang et al.
Obesity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by hepatic lipid accumulation and impaired lipid metabolism. Enhancing lipophagy, the autophagic degradation of lipid droplets, represents a pr...
Yan Wu,Xuewan Ge,Dongbiao Yu et al. Yan Wu et al.
Dapagliflozin (DAPA) is the first sodium-glucose cotransporter 2 (SGLT2) inhibitor to receive approval for clinical use in China. However, the mechanism behind the cardioprotective effects of DAPA remains unclear, as cardiac tissue does not...
Masaharu Kabashima,Nao Hasuzawa,Lixiang Wang et al. Masaharu Kabashima et al.
Although liver fibrosis presents a substantial global health challenge, therapeutic options that directly target liver fibrosis remain limited. Hepatic stellate cells (HSCs) are key contributors to fibrosis through extracellular matrix prod...
Yan-Lai Zhang,Jia-Xin Yin,Qun Liu et al. Yan-Lai Zhang et al.
Hepatocellular carcinoma (HCC) is a prevalent and aggressive liver cancer with limited treatment options and poor prognosis. Glucosamine (GlcN), a widely used dietary supplement, demonstrates anti-inflammatory properties but its antitumor p...
Na Young Kim,Mina Lee,Yejin Hong et al. Na Young Kim et al.
HER2 (human epidermal growth factor receptor 2) is a well-established oncogenic driver and therapeutic target in breast cancer. Cannabidiol (CBD), a non-psychoactive phytocannabinoid, has demonstrated anticancer potential, yet its mechanism...
Shu-Jin Li,Xiao-He Wang,Ling-Rui Li et al. Shu-Jin Li et al.
While immunotherapy has demonstrated remarkable therapeutic potential in certain malignancies, its overall clinical efficacy remains suboptimal. Emerging evidence indicates that the tumor microenvironment (TME) plays a pivotal role in deter...
Zijian Liu,Jingsheng Yuan,Qiwen Zeng et al. Zijian Liu et al.
The heterogeneous tumor microenvironment (TME) plays a critical role in the initiation and progression of hepatocellular carcinoma (HCC). Within the TME, tumor vascular endothelial cells (ECs) are key stromal components that drive angiogene...